首页 > 最新文献

International Journal of Endocrinology and Metabolism最新文献

英文 中文
Diabetic Ketoacidosis in Children Before and During COVID-19 Pandemic: A Cross-sectional Study. 新冠肺炎大流行前和期间儿童糖尿病酮酸中毒:一项跨部门研究。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-04-03 eCollection Date: 2023-04-01 DOI: 10.5812/ijem-132809
Mahtab Ordooei, Mehran Karimi, Elahe Akbarian, Zahra Rasoulizadeh
Background Coronavirus disease 2019 (COVID-19) has spread quickly. Comorbidities, such as diabetes, have been determined as critical risk factors for COVID-19. Objectives This study aimed to determine the frequency and severity of diabetic ketoacidosis (DKA) in children before and during the COVID-19 pandemic. Methods This retrospective study examined children aged less than 18 years diagnosed with DKA hospitalized in Yazd Shahid Sadoughi Hospital from February 20, 2020, to November 21, 2021. The collected information was compared to those obtained during the same period in 2019 (pre-pandemic). According to the inclusion criteria, only children with suspected symptoms of COVID-19 or an infected family member underwent PCR. Results The study included 70 children with confirmed DKA during the COVID-19 pandemic and 33 children hospitalized during the pre-pandemic period. The findings showed that the rate of DKA was higher during the pandemic than in the pre-pandemic period. In the DKA subgroups (during the COVID-19 pandemic vs. pre-pandemic), 35.7% vs. 21.2% were severe, 37.1% vs. 36.4% were moderate, and 27.1% vs. 42.4% were mild. Of 70 children, 30 underwent PCR tests for COVID-19, showing six positive cases. Among positive cases, five had mild symptoms, while one was hospitalized with signs of respiratory distress, polyuria, and polydipsia. All physical examinations of this patient were normal, except for the chest exam. Conclusions A remarkable increase was observed in the frequency and severity of DKA in children during the pandemic.
背景:2019冠状病毒病(新冠肺炎)迅速蔓延。糖尿病等合并症已被确定为新冠肺炎的关键危险因素。目的:本研究旨在确定新冠肺炎大流行前和期间儿童糖尿病酮酸中毒(DKA)的频率和严重程度。方法:这项回顾性研究检查了2020年2月20日至2021年11月21日在亚兹德·沙希德·萨杜吉医院住院的18岁以下诊断为DKA的儿童。将收集到的信息与2019年同期(疫情前)获得的信息进行了比较。根据纳入标准,只有有新冠肺炎疑似症状的儿童或受感染的家庭成员才接受PCR。结果:该研究包括70名在新冠肺炎大流行期间确诊DKA的儿童和33名在大流行前住院的儿童。研究结果表明,在疫情期间,DKA的发病率高于疫情前。在DKA亚组中(在新冠肺炎大流行期间与大流行前),35.7%对21.2%为重度,37.1%对36.4%为中度,27.1%对42.4%为轻度。在70名儿童中,30人接受了新冠肺炎PCR检测,显示6例阳性病例。在阳性病例中,5例症状轻微,1例因呼吸窘迫、多尿和多饮症状住院。除胸部检查外,该患者的所有身体检查均正常。结论:在疫情期间,儿童DKA的频率和严重程度显著增加。
{"title":"Diabetic Ketoacidosis in Children Before and During COVID-19 Pandemic: A Cross-sectional Study.","authors":"Mahtab Ordooei, Mehran Karimi, Elahe Akbarian, Zahra Rasoulizadeh","doi":"10.5812/ijem-132809","DOIUrl":"10.5812/ijem-132809","url":null,"abstract":"Background Coronavirus disease 2019 (COVID-19) has spread quickly. Comorbidities, such as diabetes, have been determined as critical risk factors for COVID-19. Objectives This study aimed to determine the frequency and severity of diabetic ketoacidosis (DKA) in children before and during the COVID-19 pandemic. Methods This retrospective study examined children aged less than 18 years diagnosed with DKA hospitalized in Yazd Shahid Sadoughi Hospital from February 20, 2020, to November 21, 2021. The collected information was compared to those obtained during the same period in 2019 (pre-pandemic). According to the inclusion criteria, only children with suspected symptoms of COVID-19 or an infected family member underwent PCR. Results The study included 70 children with confirmed DKA during the COVID-19 pandemic and 33 children hospitalized during the pre-pandemic period. The findings showed that the rate of DKA was higher during the pandemic than in the pre-pandemic period. In the DKA subgroups (during the COVID-19 pandemic vs. pre-pandemic), 35.7% vs. 21.2% were severe, 37.1% vs. 36.4% were moderate, and 27.1% vs. 42.4% were mild. Of 70 children, 30 underwent PCR tests for COVID-19, showing six positive cases. Among positive cases, five had mild symptoms, while one was hospitalized with signs of respiratory distress, polyuria, and polydipsia. All physical examinations of this patient were normal, except for the chest exam. Conclusions A remarkable increase was observed in the frequency and severity of DKA in children during the pandemic.","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"21 2","pages":"e132809"},"PeriodicalIF":2.1,"publicationDate":"2023-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c3/8b/ijem-21-2-132809.PMC10474797.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10524568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes Ketoacidosis and COVID-19: An Insight into the Pathophysiology. 糖尿病酮症酸中毒与COVID-19:病理生理学的洞察。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-04-01 DOI: 10.5812/ijem-133631
Seyed Amirabbas Ahadiat, Zeinab Hosseinian
{"title":"Diabetes Ketoacidosis and COVID-19: An Insight into the Pathophysiology.","authors":"Seyed Amirabbas Ahadiat,&nbsp;Zeinab Hosseinian","doi":"10.5812/ijem-133631","DOIUrl":"https://doi.org/10.5812/ijem-133631","url":null,"abstract":"<jats:p />","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"21 2","pages":"e133631"},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e1/8d/ijem-21-2-133631.PMC10467579.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10659944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Metformin in COVID-19: Is There a Role Beyond Glycemic Control? 二甲双胍在COVID-19中的作用:除了控制血糖之外还有其他作用吗?
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-04-01 DOI: 10.5812/ijem-132965
Lakshmi Nagendra, Saptarshi Bhattacharya, Sanjay Kalra, Nitin Kapoor

Context: The coronavirus disease 2019 (COVID-19) pandemic is still a cause of worldwide health concern. Diabetes and its associated comorbidities are risk factors for mortality and morbidity in COVID-19. Selecting the right antidiabetic drug to achieve optimal glycemic control might mitigate some of the negative impacts of diabetes. Metformin continues to be the most widely administered antidiabetic agent. There is evidence of its beneficial outcome in COVID-19 independent of its glucose-lowering effect.

Evidence acquisition: A thorough literature search was conducted in PubMed, Google Scholar, Scopus, and Web of Science to identify studies investigating metformin in COVID-19.

Results: Several overlapping mechanisms have been proposed to explain its antiviral properties. It could bring about conformational changes in the angiotensin-converting enzyme-2 receptor and decrease viral entry. The effects on the mammalian target of the rapamycin pathway and cellular pH have been proposed to reduce viral protein synthesis and replication. The immunomodulatory effects of metformin might counter the detrimental effects of hyperinflammation associated with COVID-19.

Conclusions: These findings call for broader metformin usage to manage hyperglycemia in COVID-19.

背景:2019冠状病毒病(COVID-19)大流行仍然是全球健康关注的一个原因。糖尿病及其相关合并症是COVID-19患者死亡和发病的危险因素。选择正确的降糖药来达到最佳的血糖控制可能会减轻糖尿病的一些负面影响。二甲双胍仍然是最广泛使用的降糖药。有证据表明其在COVID-19中的有益结果独立于其降血糖作用。证据获取:在PubMed、Google Scholar、Scopus和Web of Science中进行了全面的文献检索,以确定调查二甲双胍在COVID-19中的作用的研究。结果:提出了几种重叠机制来解释其抗病毒特性。它可以引起血管紧张素转换酶-2受体的构象改变,减少病毒的进入。雷帕霉素途径对哺乳动物靶点和细胞pH的影响已被提出,以减少病毒蛋白的合成和复制。二甲双胍的免疫调节作用可能会抵消与COVID-19相关的过度炎症的有害影响。结论:这些发现呼吁更广泛地使用二甲双胍来控制COVID-19患者的高血糖。
{"title":"Metformin in COVID-19: Is There a Role Beyond Glycemic Control?","authors":"Lakshmi Nagendra,&nbsp;Saptarshi Bhattacharya,&nbsp;Sanjay Kalra,&nbsp;Nitin Kapoor","doi":"10.5812/ijem-132965","DOIUrl":"https://doi.org/10.5812/ijem-132965","url":null,"abstract":"<p><strong>Context: </strong>The coronavirus disease 2019 (COVID-19) pandemic is still a cause of worldwide health concern. Diabetes and its associated comorbidities are risk factors for mortality and morbidity in COVID-19. Selecting the right antidiabetic drug to achieve optimal glycemic control might mitigate some of the negative impacts of diabetes. Metformin continues to be the most widely administered antidiabetic agent. There is evidence of its beneficial outcome in COVID-19 independent of its glucose-lowering effect.</p><p><strong>Evidence acquisition: </strong>A thorough literature search was conducted in PubMed, Google Scholar, Scopus, and Web of Science to identify studies investigating metformin in COVID-19.</p><p><strong>Results: </strong>Several overlapping mechanisms have been proposed to explain its antiviral properties. It could bring about conformational changes in the angiotensin-converting enzyme-2 receptor and decrease viral entry. The effects on the mammalian target of the rapamycin pathway and cellular pH have been proposed to reduce viral protein synthesis and replication. The immunomodulatory effects of metformin might counter the detrimental effects of hyperinflammation associated with COVID-19.</p><p><strong>Conclusions: </strong>These findings call for broader metformin usage to manage hyperglycemia in COVID-19.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"21 2","pages":"e132965"},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d6/a7/ijem-21-2-132965.PMC10467582.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10127539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-reported Male Infertility and Metabolic Disturbance: A Cross-Sectional Study. 自我报告的男性不育症和代谢紊乱:一项横断面研究。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-04-01 DOI: 10.5812/ijem-134895
Mahbanoo Farhadi-Azar, Marzieh Saei Ghare Naz, Mehrdad Ghahremani, Maryam Mousavi, Fereidoun Azizi, Fahimeh Ramezani Tehrani

Background: Male infertility is a growing health problem. It is proposed that infertility is associated with some metabolic abnormalities.

Objectives: This study aimed to examine the prevalence of self-reported male infertility and related metabolic disturbances.

Methods: This is a cross-sectional analysis of the Tehran Lipid and Glucose Study (TLGS). A total of 1526 males participated in the study. Logistic regression was used to examine metabolic factors associated with self-reported male infertility.

Results: The total prevalence of self-reported male infertility was 6.42%. The mean (SD) body mass index (BMI) of participants among fertile and infertile males was 26.80 (3.93) and 26.92 (4.36), respectively. The majority of participants in both groups were in the age group of 40-50 years old. In the fully adjusted model, the odds of infertility were significantly increased by each unit increase in total cholesterol [TC; odds ratio (OR), 1.01; 95% CI, 1.01 - 1.01; P = 0.03] and hip circumference (HC; OR, 1.06; 95% CI, 1.00 - 1.12; P = 0.02), respectively.

Conclusions: The prevalence of self-reported male infertility was 6.42%. Male infertility was positively associated with TC and HC, indicating that knowledge about these risks might assist health care professionals and governments in developing and executing measures to change the status quo.

背景:男性不育是一个日益严重的健康问题。有人认为不孕症与某些代谢异常有关。目的:本研究旨在调查自我报告的男性不育症和相关代谢紊乱的患病率。方法:这是德黑兰脂质和葡萄糖研究(TLGS)的横断面分析。共有1526名男性参与了这项研究。使用Logistic回归来检查与自我报告的男性不育症相关的代谢因素。结果:自述男性不育症总患病率为6.42%。可育男性和不育男性的平均体重指数(BMI)分别为26.80(3.93)和26.92(4.36)。两组的大多数参与者年龄在40-50岁之间。在完全调整模型中,总胆固醇每增加一个单位,不孕的几率显著增加[TC;优势比(OR), 1.01;95% ci, 1.01 - 1.01;P = 0.03]和臀围(HC;或者,1.06;95% ci, 1.00 - 1.12;P = 0.02)。结论:自述男性不育症患病率为6.42%。男性不育与TC和HC呈正相关,表明了解这些风险可能有助于卫生保健专业人员和政府制定和执行改变现状的措施。
{"title":"Self-reported Male Infertility and Metabolic Disturbance: A Cross-Sectional Study.","authors":"Mahbanoo Farhadi-Azar,&nbsp;Marzieh Saei Ghare Naz,&nbsp;Mehrdad Ghahremani,&nbsp;Maryam Mousavi,&nbsp;Fereidoun Azizi,&nbsp;Fahimeh Ramezani Tehrani","doi":"10.5812/ijem-134895","DOIUrl":"https://doi.org/10.5812/ijem-134895","url":null,"abstract":"<p><strong>Background: </strong>Male infertility is a growing health problem. It is proposed that infertility is associated with some metabolic abnormalities.</p><p><strong>Objectives: </strong>This study aimed to examine the prevalence of self-reported male infertility and related metabolic disturbances.</p><p><strong>Methods: </strong>This is a cross-sectional analysis of the Tehran Lipid and Glucose Study (TLGS). A total of 1526 males participated in the study. Logistic regression was used to examine metabolic factors associated with self-reported male infertility.</p><p><strong>Results: </strong>The total prevalence of self-reported male infertility was 6.42%. The mean (SD) body mass index (BMI) of participants among fertile and infertile males was 26.80 (3.93) and 26.92 (4.36), respectively. The majority of participants in both groups were in the age group of 40-50 years old. In the fully adjusted model, the odds of infertility were significantly increased by each unit increase in total cholesterol [TC; odds ratio (OR), 1.01; 95% CI, 1.01 - 1.01; P = 0.03] and hip circumference (HC; OR, 1.06; 95% CI, 1.00 - 1.12; P = 0.02), respectively.</p><p><strong>Conclusions: </strong>The prevalence of self-reported male infertility was 6.42%. Male infertility was positively associated with TC and HC, indicating that knowledge about these risks might assist health care professionals and governments in developing and executing measures to change the status quo.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"21 2","pages":"e134895"},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/de/ijem-21-2-134895.PMC10467580.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10136682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neck Ganglioneuroma Mimicking a Thyroid Nodule in a Four-Year-Old Child: A Case Report and Review of the Literature. 1例4岁儿童颈部神经节神经瘤伴甲状腺结节:1例报告及文献复习。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-04-01 DOI: 10.5812/ijem-126486
Stefania Corrado, Cesare Morgante, Sauro Tassi, Francesco Maccarrone, Gianluca Di Massa, Alfredo Pontecorvi, Giampaolo Papi

Introduction: Ganglioneuromas are tumors of neurogenic origin usually located in the abdomen, the adrenal glands, and the mediastinum but infrequently found in the neck region.

Case presentation: We describe the case of a four-year-old Albanian girl presenting with an anterior neck mass initially suspected to be a thyroid nodule. From a clinical point of view, there was no evidence of compression on vital cervical structures. Lab tests detected normal serum thyrotropin, calcitonin, and parathormone concentrations. A neck ultrasound showed a huge mass apparently originating from the left thyroid lobe. Cytological examination of fine needle biopsy demonstrated a population of large cells with eosinophilic cytoplasm, regular nuclei, and prominent nucleoli and spindle cells without significant atypia, consistent with a benign lesion of neurogenic origin. Also, the neck MRI displayed a mass with well-defined margins, likely arising from the peripheral nervous system. The patient underwent surgical excision of the mass without complications. The histological exam was diagnostic for ganglioneuroma.

Conclusions: We discuss the cytological and histological features peculiar to such a rare neck lesion and review the differential diagnosis.

神经节神经瘤是一种神经源性肿瘤,通常位于腹部、肾上腺和纵隔,但很少发生在颈部。病例介绍:我们描述了一个四岁的阿尔巴尼亚女孩的情况下,提出了一个前颈部肿块最初怀疑是甲状腺结节。从临床角度来看,没有证据表明颈椎重要结构受到压迫。实验室检测血清促甲状腺素、降钙素和甲状旁腺激素浓度正常。颈部超音波显示一巨大肿块,明显源自左甲状腺叶。细针活检细胞学检查显示大细胞群嗜酸性细胞质,细胞核规则,核仁和梭形细胞突出,无明显异型性,符合神经源性良性病变。同时,颈部MRI显示肿块边界清晰,可能来自周围神经系统。患者接受手术切除肿块,无并发症。组织学检查诊断为神经节神经瘤。结论:我们讨论了这种罕见的颈部病变的细胞学和组织学特征,并回顾了鉴别诊断。
{"title":"Neck Ganglioneuroma Mimicking a Thyroid Nodule in a Four-Year-Old Child: A Case Report and Review of the Literature.","authors":"Stefania Corrado,&nbsp;Cesare Morgante,&nbsp;Sauro Tassi,&nbsp;Francesco Maccarrone,&nbsp;Gianluca Di Massa,&nbsp;Alfredo Pontecorvi,&nbsp;Giampaolo Papi","doi":"10.5812/ijem-126486","DOIUrl":"https://doi.org/10.5812/ijem-126486","url":null,"abstract":"<p><strong>Introduction: </strong>Ganglioneuromas are tumors of neurogenic origin usually located in the abdomen, the adrenal glands, and the mediastinum but infrequently found in the neck region.</p><p><strong>Case presentation: </strong>We describe the case of a four-year-old Albanian girl presenting with an anterior neck mass initially suspected to be a thyroid nodule. From a clinical point of view, there was no evidence of compression on vital cervical structures. Lab tests detected normal serum thyrotropin, calcitonin, and parathormone concentrations. A neck ultrasound showed a huge mass apparently originating from the left thyroid lobe. Cytological examination of fine needle biopsy demonstrated a population of large cells with eosinophilic cytoplasm, regular nuclei, and prominent nucleoli and spindle cells without significant atypia, consistent with a benign lesion of neurogenic origin. Also, the neck MRI displayed a mass with well-defined margins, likely arising from the peripheral nervous system. The patient underwent surgical excision of the mass without complications. The histological exam was diagnostic for ganglioneuroma.</p><p><strong>Conclusions: </strong>We discuss the cytological and histological features peculiar to such a rare neck lesion and review the differential diagnosis.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"21 2","pages":"e126486"},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f4/eb/ijem-21-2-126486.PMC10474842.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10151319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of a Reduced-Calorie Diet on Plasma Levels of Inflammatory and Metabolic Factors in Overweight/Obese Patients with Cardiovascular Risk Factors. 低热量饮食对伴有心血管危险因素的超重/肥胖患者血浆炎症和代谢因子水平的影响
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-04-01 DOI: 10.5812/ijem-135216
Javad Nasrollahzadeh, Nafiseh Khandouzi, Mahsa Maroofi

Background: Calorie restriction without malnutrition is likely to improve cardiovascular risk factors.

Objectives: The aim of this study was to investigate calorie restriction on markers of cardiometabolic risk in overweight/obese adults with cardiovascular risk factors.

Methods: In a parallel controlled trial, patients with overweight or obesity and one or more cardiovascular risk factor were randomized to a modest reduced-calorie diet (75% of the total calculated energy requirements) or control (no calorie restriction) groups and followed up for two months. Body weight, dietary intake, fasting plasma levels of C-reactive protein (CRP), monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), brain-derived neurotrophic factor (BDNF), neuropeptide Y (NPY), lipids, and glycemic factors were measured at baseline, and after two months. The differences were analyzed with analysis of covariance (ANCOVA).

Results: Sixty-six participants (33 in each group) completed the study. Body weight changed in the reduced-calorie diet group (- 3.05 ± 2.65 kg), and blood pressure was improved (systolic -6.96 ± 12.04 and diastolic - 3.90 ± 8.97 mmHg). The reduced-calorie diet improved plasma ICAM-1 (change from baseline - 0.45 ± 1.99 ng/mL, P = 0.033, ANCOVA), MCP-1 (change from baseline - 0.50 pg/mL, P = 0.011, ANCOVA), low-density lipoprotein cholesterol (change from baseline - 9.35 ± 19.61 mg/dL, P < 0.001, ANCOVA), and triglyceride (change from baseline -33.66 ± 49.08, P = 0.001, ANCOVA), but BDNF, NPY, and other cardiometabolic factors were not different.

Conclusions: In overweight/obese subjects with cardiovascular risk factors which have been under medical treatment with risk-reducing medications, a modest weight loss induced by a reduced-calorie diet improved lipid profile, blood pressure, and reduced ICAM-1 and MCP-1 levels but had no effect on plasma BDNF or glycemic factors.

背景:没有营养不良的热量限制可能改善心血管危险因素。目的:本研究的目的是调查卡路里限制对有心血管危险因素的超重/肥胖成年人的心脏代谢危险标志物的影响。方法:在一项平行对照试验中,超重或肥胖且有一种或多种心血管危险因素的患者被随机分为适度减少卡路里饮食(占总计算能量需求的75%)或对照组(无卡路里限制),随访2个月。在基线和两个月后测量体重、饮食摄入量、空腹血浆c反应蛋白(CRP)、单核细胞趋化蛋白-1 (MCP-1)、细胞间粘附分子1 (ICAM-1)、血管细胞粘附分子1 (VCAM-1)、脑源性神经营养因子(BDNF)、神经肽Y (NPY)、血脂和血糖因子水平。采用协方差分析(ANCOVA)对差异进行分析。结果:66名参与者(每组33名)完成了研究。低热量饮食组体重改变(- 3.05±2.65 kg),血压改善(收缩压-6.96±12.04,舒张压- 3.90±8.97 mmHg)。低热量饮食改善了血浆ICAM-1(较基线变化为- 0.45±1.99 ng/mL, P = 0.033, ANCOVA)、MCP-1(较基线变化为- 0.50 pg/mL, P = 0.011, ANCOVA)、低密度脂蛋白胆固醇(较基线变化为- 9.35±19.61 mg/dL, P < 0.001, ANCOVA)和甘油三酯(较基线变化为-33.66±49.08,P = 0.001, ANCOVA),但BDNF、NPY和其他心脏代谢因子无差异。结论:在有心血管危险因素的超重/肥胖受试者中,通过降低风险的药物治疗,低热量饮食引起的适度体重减轻改善了血脂、血压,降低了ICAM-1和MCP-1水平,但对血浆BDNF或血糖因子没有影响。
{"title":"Effect of a Reduced-Calorie Diet on Plasma Levels of Inflammatory and Metabolic Factors in Overweight/Obese Patients with Cardiovascular Risk Factors.","authors":"Javad Nasrollahzadeh,&nbsp;Nafiseh Khandouzi,&nbsp;Mahsa Maroofi","doi":"10.5812/ijem-135216","DOIUrl":"https://doi.org/10.5812/ijem-135216","url":null,"abstract":"<p><strong>Background: </strong>Calorie restriction without malnutrition is likely to improve cardiovascular risk factors.</p><p><strong>Objectives: </strong>The aim of this study was to investigate calorie restriction on markers of cardiometabolic risk in overweight/obese adults with cardiovascular risk factors.</p><p><strong>Methods: </strong>In a parallel controlled trial, patients with overweight or obesity and one or more cardiovascular risk factor were randomized to a modest reduced-calorie diet (75% of the total calculated energy requirements) or control (no calorie restriction) groups and followed up for two months. Body weight, dietary intake, fasting plasma levels of C-reactive protein (CRP), monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), brain-derived neurotrophic factor (BDNF), neuropeptide Y (NPY), lipids, and glycemic factors were measured at baseline, and after two months. The differences were analyzed with analysis of covariance (ANCOVA).</p><p><strong>Results: </strong>Sixty-six participants (33 in each group) completed the study. Body weight changed in the reduced-calorie diet group (- 3.05 ± 2.65 kg), and blood pressure was improved (systolic -6.96 ± 12.04 and diastolic - 3.90 ± 8.97 mmHg). The reduced-calorie diet improved plasma ICAM-1 (change from baseline - 0.45 ± 1.99 ng/mL, P = 0.033, ANCOVA), MCP-1 (change from baseline - 0.50 pg/mL, P = 0.011, ANCOVA), low-density lipoprotein cholesterol (change from baseline - 9.35 ± 19.61 mg/dL, P < 0.001, ANCOVA), and triglyceride (change from baseline -33.66 ± 49.08, P = 0.001, ANCOVA), but BDNF, NPY, and other cardiometabolic factors were not different.</p><p><strong>Conclusions: </strong>In overweight/obese subjects with cardiovascular risk factors which have been under medical treatment with risk-reducing medications, a modest weight loss induced by a reduced-calorie diet improved lipid profile, blood pressure, and reduced ICAM-1 and MCP-1 levels but had no effect on plasma BDNF or glycemic factors.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"21 2","pages":"e135216"},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2f/5d/ijem-21-2-135216.PMC10467581.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10136683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential Methods to Improve Self-management in Those with Type 2 Diabetes: A Narrative Review. 改善2型糖尿病患者自我管理的潜在方法:综述
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 DOI: 10.5812/ijem-119698
Tintin Sukartini, Nursalam Nursalam, Rifky Octavia Pradipta, Masunatul Ubudiyah

Context: The ability of self-manage was important for type 2 diabetes mellitus (T2DM) patients and it was supported and depend on the method used. We aimed to summarize the potential method of self-management to improve self-empowerment.

Evidence acquisition: To obtain the related data, 5 databases, including Scopus, Science Direct, ProQuest, CINAHL, and SAGE, were comprehensively searched. The search was done in advance using the Boolean operator. The full texts of articles presenting data on self-management methods were screened and retrieved.

Results: A total of 22 studies were included in this review. Various self-management techniques were covered with primary and secondary outcomes. Primary outcomes included blood pressure, fasting blood glucose (FBG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL). Secondary outcomes included knowledge, self-efficacy, lifestyle habits, physical activity, diet, smoking, medical treatment, support, and health behavior. A goal-setting-oriented approach was effective in setting targets and gaining support from family members. A family-centered approach was effective in taking care of and taking good care of patients with T2DM. Strength training exercises provide patients with a choice of physical activity that can help them manage their blood sugar and blood pressure. Acceptance and commitment therapy (ACT) is a stress-reduction technique. The patient's acceptance of the disease and treatment for diabetes is aided by education.

Conclusions: A successful self-management method was one which balances and adapts to the patient's condition. Regardless of the age of the patients, the overall findings from the review suggest that self-management methods can help patients become healthier and improve their quality of life by controlling their hemoglobin A1c (HbA1c) level.

背景:自我管理能力对2型糖尿病(T2DM)患者很重要,它得到了支持,并取决于所使用的方法。我们旨在总结自我管理的潜在方法,以提高自我授权。证据获取:为获取相关数据,综合检索Scopus、Science Direct、ProQuest、CINAHL、SAGE 5个数据库。搜索是使用布尔运算符提前完成的。筛选和检索有关自我管理方法数据的文章全文。结果:本综述共纳入22项研究。各种自我管理技术包括主要和次要结果。主要结局包括血压、空腹血糖(FBG)、低密度脂蛋白(LDL)和高密度脂蛋白(HDL)。次要结局包括知识、自我效能、生活习惯、身体活动、饮食、吸烟、医疗、支持和健康行为。以设定目标为导向的方法在设定目标和获得家庭成员的支持方面是有效的。以家庭为中心的方法在照顾和照顾T2DM患者方面是有效的。力量训练为患者提供了一种选择,可以帮助他们控制血糖和血压。接受和承诺疗法(ACT)是一种减压技术。教育有助于患者接受糖尿病和治疗。结论:一个成功的自我管理方法是一个平衡和适应病人的情况。无论患者的年龄如何,综述的总体结果表明,自我管理方法可以通过控制他们的血红蛋白A1c (HbA1c)水平来帮助患者变得更健康,提高他们的生活质量。
{"title":"Potential Methods to Improve Self-management in Those with Type 2 Diabetes: A Narrative Review.","authors":"Tintin Sukartini,&nbsp;Nursalam Nursalam,&nbsp;Rifky Octavia Pradipta,&nbsp;Masunatul Ubudiyah","doi":"10.5812/ijem-119698","DOIUrl":"https://doi.org/10.5812/ijem-119698","url":null,"abstract":"<p><strong>Context: </strong>The ability of self-manage was important for type 2 diabetes mellitus (T2DM) patients and it was supported and depend on the method used. We aimed to summarize the potential method of self-management to improve self-empowerment.</p><p><strong>Evidence acquisition: </strong>To obtain the related data, 5 databases, including Scopus, Science Direct, ProQuest, CINAHL, and SAGE, were comprehensively searched. The search was done in advance using the Boolean operator. The full texts of articles presenting data on self-management methods were screened and retrieved.</p><p><strong>Results: </strong>A total of 22 studies were included in this review. Various self-management techniques were covered with primary and secondary outcomes. Primary outcomes included blood pressure, fasting blood glucose (FBG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL). Secondary outcomes included knowledge, self-efficacy, lifestyle habits, physical activity, diet, smoking, medical treatment, support, and health behavior. A goal-setting-oriented approach was effective in setting targets and gaining support from family members. A family-centered approach was effective in taking care of and taking good care of patients with T2DM. Strength training exercises provide patients with a choice of physical activity that can help them manage their blood sugar and blood pressure. Acceptance and commitment therapy (ACT) is a stress-reduction technique. The patient's acceptance of the disease and treatment for diabetes is aided by education.</p><p><strong>Conclusions: </strong>A successful self-management method was one which balances and adapts to the patient's condition. Regardless of the age of the patients, the overall findings from the review suggest that self-management methods can help patients become healthier and improve their quality of life by controlling their hemoglobin A1c (HbA1c) level.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"21 1","pages":"e119698"},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1d/dd/ijem-21-1-119698.PMC10082325.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9289128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Risk Reassessment of Differentiated Thyroid Cancer in Ahvaz, Iran: A Cross-sectional Retrospective Study. 伊朗阿瓦士地区分化性甲状腺癌的风险再评估:一项横断面回顾性研究。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 DOI: 10.5812/ijem-130434
Alireza Jahanshahi, Atefeh Asoodeh Sarshoori, Homeira Rashidi, Ferdos Zaman, Leila Moradi

Background: Accurate evaluation of response to treatment in differentiated thyroid cancer (DTC) is the sine qua non of preventing over-treatment in low-risk patients and implementing appropriate interventions in high-risk individuals.

Objectives: This study aimed to assess the response to therapy in DTC patients based on dynamic stratification method.

Methods: In this cross-sectional study, 154 medical records of subjects with DTC (with at least 6 months after total thyroidectomy) and referred to endocrinology clinics in Ahvaz, Iran, from April 2020 to May 2021 were examined. Patients were stratified according to a dynamic risk stratification system (informed by their specific clinical, histopathological, and ultrasonography findings, and other diagnostic imagines) into four groups: Excellent response (ER), indeterminate response (IR), biochemical incomplete response (BIR), and structural incomplete response (SIR).

Results: For a mean follow-up period of 28.59 months, excellent response to treatment was observed in 92 patients (59.7%), indeterminate response to treatment was found in 32 patients (20.8%), biochemical incomplete response was detected in 2 patients (1.3%), and structural incomplete response was seen in 28 patients (18.2%). In the group with low risk of recurrence, ER and IR were observed in 79.2% and 15.6% of the patients, respectively (P < 0.0001). In the group with an intermediate risk of recurrence, ER was found in 32% of the patients, while IR and SIR + BIR were seen in 34% and 34% of the patients, respectively (P < 0.0001). No cases of ER or IR were observed in the group with high risk (P = 0.001).

Conclusions: In sum, response to treatment significantly varied based on dynamic risk stratification, with ER being highest in the low-risk group, less likely in moderate risk group, and undetected in the high-risk group.

背景:准确评估分化型甲状腺癌(DTC)治疗反应是预防低危患者过度治疗和高危人群实施适当干预的必要条件。目的:本研究旨在基于动态分层法评估DTC患者的治疗反应。方法:在这项横断面研究中,研究了2020年4月至2021年5月在伊朗阿瓦士(Ahvaz)内分泌科诊所就诊的154例DTC患者(甲状腺全切除术后至少6个月)的医疗记录。根据动态风险分层系统(根据患者的具体临床、组织病理学、超声检查结果和其他诊断图像)将患者分为四组:优异反应(ER)、不确定反应(IR)、生化不完全反应(BIR)和结构不完全反应(SIR)。结果:在平均28.59个月的随访中,92例(59.7%)患者对治疗反应良好,32例(20.8%)患者对治疗反应不确定,2例(1.3%)患者发现生化不完全缓解,28例(18.2%)患者发现结构性不完全缓解。低复发风险组ER和IR发生率分别为79.2%和15.6% (P < 0.0001)。在中度复发风险组中,ER发生率为32%,IR和SIR + BIR分别为34%和34% (P < 0.0001)。高危组未见ER或IR病例(P = 0.001)。结论:总而言之,基于动态风险分层,治疗反应存在显著差异,低危组ER发生率最高,中危组ER发生率较低,高危组未被发现。
{"title":"Risk Reassessment of Differentiated Thyroid Cancer in Ahvaz, Iran: A Cross-sectional Retrospective Study.","authors":"Alireza Jahanshahi,&nbsp;Atefeh Asoodeh Sarshoori,&nbsp;Homeira Rashidi,&nbsp;Ferdos Zaman,&nbsp;Leila Moradi","doi":"10.5812/ijem-130434","DOIUrl":"https://doi.org/10.5812/ijem-130434","url":null,"abstract":"<p><strong>Background: </strong>Accurate evaluation of response to treatment in differentiated thyroid cancer (DTC) is the sine qua non of preventing over-treatment in low-risk patients and implementing appropriate interventions in high-risk individuals.</p><p><strong>Objectives: </strong>This study aimed to assess the response to therapy in DTC patients based on dynamic stratification method.</p><p><strong>Methods: </strong>In this cross-sectional study, 154 medical records of subjects with DTC (with at least 6 months after total thyroidectomy) and referred to endocrinology clinics in Ahvaz, Iran, from April 2020 to May 2021 were examined. Patients were stratified according to a dynamic risk stratification system (informed by their specific clinical, histopathological, and ultrasonography findings, and other diagnostic imagines) into four groups: Excellent response (ER), indeterminate response (IR), biochemical incomplete response (BIR), and structural incomplete response (SIR).</p><p><strong>Results: </strong>For a mean follow-up period of 28.59 months, excellent response to treatment was observed in 92 patients (59.7%), indeterminate response to treatment was found in 32 patients (20.8%), biochemical incomplete response was detected in 2 patients (1.3%), and structural incomplete response was seen in 28 patients (18.2%). In the group with low risk of recurrence, ER and IR were observed in 79.2% and 15.6% of the patients, respectively (P < 0.0001). In the group with an intermediate risk of recurrence, ER was found in 32% of the patients, while IR and SIR + BIR were seen in 34% and 34% of the patients, respectively (P < 0.0001). No cases of ER or IR were observed in the group with high risk (P = 0.001).</p><p><strong>Conclusions: </strong>In sum, response to treatment significantly varied based on dynamic risk stratification, with ER being highest in the low-risk group, less likely in moderate risk group, and undetected in the high-risk group.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"21 1","pages":"e130434"},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b6/16/ijem-21-1-130434.PMC10024812.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9154429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Scientific Publishing in Biomedicine: A Brief History of Scientific Journals. 生物医学科学出版:科学期刊简史。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 DOI: 10.5812/ijem-131812
Asghar Ghasemi, Parvin Mirmiran, Khosrow Kashfi, Zahra Bahadoran

Scientific publishing, with about 350-year historical background, has played a central role in advancing science by disseminating new findings, generalizing accepted theories, and sharing novel ideas. The number of scientific journals has exponentially grown from 10 at the end of the 17th century to 100,000 at the end of the 20th century. The publishing landscape has dramatically changed over time from printed journals to online publishing. Although scientific publishing was initially non-commercial, it has become a profitable industry with a significant global financial turnover, reaching $28 billion in annual revenue before the COVID-19 pandemic. However, scientific publishing has encountered several challenges and is suffering from unethical practices and some negative phenomena, like publish-or-perish, driven by the need to survive or get a promotion in academia. Developing a global landscape with collaborative non-commercial journals and platforms is a primary proposed model for the future of scientific publishing. Here, we provide a brief history of the foundation and development of scientific journals and their evolution over time. Furthermore, current challenges and future perspectives of scientific publishing are discussed.

科学出版具有350年左右的历史背景,通过传播新发现、推广已被接受的理论和分享新思想,在推动科学发展方面发挥了核心作用。科学期刊的数量从17世纪末的10种增长到20世纪末的10万种,呈指数增长。随着时间的推移,出版业的格局发生了巨大的变化,从印刷期刊到在线出版。虽然科学出版最初是非商业性的,但它已经成为一个有利可图的行业,在全球范围内拥有可观的财务营业额,在COVID-19大流行之前,年收入达到280亿美元。然而,科学出版遇到了一些挑战,正在遭受不道德的做法和一些负面现象,比如在学术界生存或获得晋升的需要的驱使下,要么发表,要么灭亡。通过合作的非商业期刊和平台来发展全球格局是未来科学出版的主要模式。在这里,我们简要介绍了科学期刊的建立和发展以及它们随时间的演变。此外,还讨论了科学出版面临的挑战和未来的展望。
{"title":"Scientific Publishing in Biomedicine: A Brief History of Scientific Journals.","authors":"Asghar Ghasemi,&nbsp;Parvin Mirmiran,&nbsp;Khosrow Kashfi,&nbsp;Zahra Bahadoran","doi":"10.5812/ijem-131812","DOIUrl":"https://doi.org/10.5812/ijem-131812","url":null,"abstract":"<p><p>Scientific publishing, with about 350-year historical background, has played a central role in advancing science by disseminating new findings, generalizing accepted theories, and sharing novel ideas. The number of scientific journals has exponentially grown from 10 at the end of the 17th century to 100,000 at the end of the 20th century. The publishing landscape has dramatically changed over time from printed journals to online publishing. Although scientific publishing was initially non-commercial, it has become a profitable industry with a significant global financial turnover, reaching $28 billion in annual revenue before the COVID-19 pandemic. However, scientific publishing has encountered several challenges and is suffering from unethical practices and some negative phenomena, like publish-or-perish, driven by the need to survive or get a promotion in academia. Developing a global landscape with collaborative non-commercial journals and platforms is a primary proposed model for the future of scientific publishing. Here, we provide a brief history of the foundation and development of scientific journals and their evolution over time. Furthermore, current challenges and future perspectives of scientific publishing are discussed.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"21 1","pages":"e131812"},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/26/ijem-21-1-131812.PMC10024814.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9158589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Recurrent Pericardial Effusion Due to Panhypopituitarism: A Rare Case Report. 全垂体功能低下所致复发性心包积液1例报告。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 DOI: 10.5812/ijem-131341
Sher Singh Dariya, Deepak Agrawal

Introduction: A female patient, 48 years of age, with a complaint of recurrent episodes of diffuse chest pain, vertigo, and shortness of breath in the last five years, presented needing immediate medical attention.

Case presentation: The patient was evaluated and suspected of severe hypotension, cold hands, and feet with distended neck veins and muffled heart sounds. ECG revealed low voltage complexes and large pericardial effusion with a collapse in the diastole of the right auricle and ventricle. The provisional diagnosis was kept as pericardial effusion with hemodynamic compromise. Detailed history disclosed that she had suffered similar events five years before, during which a pericardial tap was performed, and the patient was on anti-tuberculosis treatment for nine months. The symptoms continued despite the treatments. She had a history of severe postpartum hemorrhage, failure of lactation, and early menopause with a history of hysterectomy dated ten years back. The biochemical study indicated decreased LH, FSH, TSH, ACTH, and serum cortisol levels. MRI brain revealed empty sella. The hormonal replacement was started with clinical improvement.

Conclusions: Although hypothyroidism is an extremely rare cause of pericardial effusion, detailed history and further investigations are imperative to form a definitive diagnosis.

简介:一名女性患者,48岁,在过去的五年里,因反复发作的弥漫性胸痛、眩晕和呼吸短促而主诉,需要立即就医。病例描述:患者经评估后怀疑为严重低血压,手脚冰冷,颈静脉扩张,心音低沉。心电图显示低电压复合体和大量心包积液,右耳廓和心室舒张塌陷。初步诊断为心包积液伴血流动力学损害。详细的病史显示,她在5年前有过类似的经历,期间曾做过心包穿刺,并接受了9个月的抗结核治疗。尽管接受了治疗,但症状仍然存在。患者有严重产后出血、泌乳失败、提前绝经史,10年前曾行子宫切除术。生化研究显示LH、FSH、TSH、ACTH和血清皮质醇水平降低。MRI显示脑鞍空。激素替代治疗在临床改善后开始。结论:虽然甲状腺功能减退是一种极为罕见的心包积液的病因,但详细的病史和进一步的检查是形成明确诊断的必要条件。
{"title":"Recurrent Pericardial Effusion Due to Panhypopituitarism: A Rare Case Report.","authors":"Sher Singh Dariya,&nbsp;Deepak Agrawal","doi":"10.5812/ijem-131341","DOIUrl":"https://doi.org/10.5812/ijem-131341","url":null,"abstract":"<p><strong>Introduction: </strong>A female patient, 48 years of age, with a complaint of recurrent episodes of diffuse chest pain, vertigo, and shortness of breath in the last five years, presented needing immediate medical attention.</p><p><strong>Case presentation: </strong>The patient was evaluated and suspected of severe hypotension, cold hands, and feet with distended neck veins and muffled heart sounds. ECG revealed low voltage complexes and large pericardial effusion with a collapse in the diastole of the right auricle and ventricle. The provisional diagnosis was kept as pericardial effusion with hemodynamic compromise. Detailed history disclosed that she had suffered similar events five years before, during which a pericardial tap was performed, and the patient was on anti-tuberculosis treatment for nine months. The symptoms continued despite the treatments. She had a history of severe postpartum hemorrhage, failure of lactation, and early menopause with a history of hysterectomy dated ten years back. The biochemical study indicated decreased LH, FSH, TSH, ACTH, and serum cortisol levels. MRI brain revealed empty sella. The hormonal replacement was started with clinical improvement.</p><p><strong>Conclusions: </strong>Although hypothyroidism is an extremely rare cause of pericardial effusion, detailed history and further investigations are imperative to form a definitive diagnosis.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"21 1","pages":"e131341"},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1d/5a/ijem-21-1-131341.PMC10024806.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9154428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Endocrinology and Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1